| Company | Date | Position | Consensus ⓘ | Price Target ⓘ | 1-Yr Return |
|---|---|---|---|---|---|
|
ARAY
Accuray
|
May 12, 2026 | HOLD |
Buy
+1755.0% avg upside
9 analysts
|
$0.35
11.85% Upside
|
· |
|
TMDX
TransMedics Group
|
Oct 28, 2025 | BUY |
Strong Buy
+55.0% avg upside
15 analysts
|
$145.00
92.09% Upside
|
-39.3% |
|
CH:ALC
Alcon
|
Aug 06, 2025 | BUY |
Buy
+34.6% avg upside
35 analysts
|
$92.96
74.29% Upside
|
· |
|
RXST
RxSight
|
Jul 10, 2025 | HOLD |
Hold
+126.0% avg upside
13 analysts
|
$9.00
81.54% Upside
|
-29.1% |
|
ENOV
Enovis
|
May 30, 2025 | BUY |
Strong Buy
+222.1% avg upside
37 analysts
|
$60.00
181.71% Upside
|
-20.5% |
|
COO
Cooper Co
|
Apr 13, 2025 | BUY |
Strong Buy
+103.1% avg upside
21 analysts
|
$105.00
60.43% Upside
|
-9.0% |
|
HYPR
Hyperfine
|
Mar 18, 2025 | HOLD |
Strong Buy
+30.9% avg upside
6 analysts
|
$1.20
19.51% Downside
|
+39.2% |
|
STAA
Staar Surgical
|
Feb 12, 2025 | HOLD |
Hold
+15.0% avg upside
16 analysts
|
$18.00
37.55% Downside
|
+0.1% |
|
ATEC
Alphatec Holdings
|
Jan 14, 2025 | BUY |
Strong Buy
+115.5% avg upside
22 analysts
|
$19.00
122.27% Upside
|
+43.4% |
|
BLCO
Bausch + Lomb Corporation
|
May 06, 2024 | BUY |
Buy
+30.4% avg upside
19 analysts
|
$25.00
67.43% Upside
|
-24.5% |
|
SIBN
SI-Bone
|
Mar 11, 2024 | BUY |
Strong Buy
+60.0% avg upside
18 analysts
|
$30.00
89.65% Upside
|
-12.8% |
|
VREX
Varex Imaging
|
May 23, 2023 | HOLD |
Strong Buy
+93.2% avg upside
9 analysts
|
$24.00
130.78% Upside
|
-32.3% |
|
VRAYQ
Viewray
|
Apr 16, 2023 | HOLD |
Strong Buy
+558333233.3% avg upside
12 analysts
|
$1.25
124999899.93% Upside
|
-100.0% |
|
CNMD
Conmed
|
Oct 11, 2022 | HOLD |
Hold
+82.3% avg upside
12 analysts
|
$85.00
161.22% Upside
|
+26.6% |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.